HSBC BANK PLC - FORM 8.5 (EPT/RI) - Lonmin Plc  FORM 8.5

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
143
HSBC BANK PLC - FORM 8.5 (EPT/RI) - Lonmin Plc

 FORM 8.5 EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the “Code”)

1.         KEY INFORMATION

(a) Name of exempt principal trader: HSBC BANK PLC
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:   Use a separate form for each offeror/offeree   Lonmin Plc
(c) Name of the party to the offer with which exempt principal trader is connected:   Sibanye Gold Ltd
(d) Date dealing undertaken:   05 July 2018
(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? If it is a cash offer or possible cash offer, state “N/A”   Yes – Sibanye Gold Ltd

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a)        Purchases and sales

Class of relevant security Purchases/ sales   Total number of securities Highest price per unit paid/received (GBP) Lowest price per unit paid/received (GBP)
Ordinary Shares Purchase 7,785   42.000 p   41.793 p
Ordinary Shares Sale 7,785   42.000 p   41.793 p

(b)        Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP)
         

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

3.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state “none”
    None  

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
  None
Date of disclosure: 06 July 2018
Contact name: Abdul Qader
Telephone number: 0207 088 2000

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk .  The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk .

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Exciting New Development Partnership in Wasaga Beach Focuses on Growth

Updated Category News Views 262

New Development Partnership Announcement Sunray Group of Hotels is excited to announce a letter of intent for a new development project alongside the Town of Wasaga Beach. This venture, located at the intersection of First Street North and Beach Drive, is strategically positioned on four acres of valuable land across from Beach Area One. The proposed project consists of a...

Continue Reading
iGlobal Media USA Launches $500,000 Investment Round for Growth

Updated Category News Views 231

iGlobal Media USA Opens Investment Round for Expansion iGlobal Media USA, a leading name in digital broadcasting, is excited to announce a new opportunity for investors with a significant investment round aimed at raising $500,000. This funding will be pivotal for accelerating the national expansion of its advanced cloud-based radio platform, which promises to...

Continue Reading
STMicroelectronics Shares Update: Share Repurchase Program Details

Updated Category News Views 156

STMicroelectronics Shares Update on Repurchase Program STMicroelectronics N.V. (the "Company" or "STMicroelectronics"), a prominent name in the semiconductor industry, has actively engaged in a share repurchase program aimed at enhancing shareholder value. This program, initially revealed in a previous announcement, serves as a testament to the Company's commitment to...

Continue Reading
Chicago Mayor Brandon Johnson Set to Tackle Key Issues in D.C.

Updated Category News Views 103

Chicago Mayor Brandon Johnson to Speak at National Press Club Join us for an insightful luncheon featuring Chicago Mayor Brandon Johnson as he takes the stage at the National Press Club. This important event is set for the 28th of January, providing a platform for the Mayor to discuss pressing topics affecting residents. Event Overview The Headliners Luncheon will kick...

Continue Reading
BioCryst Pharmaceuticals Reveals HRU Improvements with ORLADEYO

Updated Category News Views 184

BioCryst Pharmaceuticals Introduces New HRU Findings BioCryst Pharmaceuticals, Inc. has recently shared compelling evidence regarding their product, ORLADEYO (berotralstat), that highlights its impact on reducing healthcare resource utilization for patients suffering from hereditary angioedema (HAE). This important finding underscores the therapy's role not only in...

Continue Reading